Price targets for UDR were adjusted by Cantor Fitzgerald, Scotiabank, and Royal Bank of Canada on May 26, 2026.
10 reports, 3 independent
Updated Sep 23
Mostly repetition
- Reports
- 10
- Developments
- 3
- Repetition
- 70%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Price targets for UDR were adjusted by Cantor Fitzgerald, Scotiabank, and Royal Bank of Canada on May 26, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Rating firms RBC and Scotiabank issued price target updates for Royalties, reported by MarketBeat.1 source
RBC lowered price target for Cytokinetics; sale disclosed via SEC filing.1 source
Analysts lowered and raised price targets for UDR on May 26, 2026.1 source
Keep exploring
The entities involved
-
UDR
real estate investment firm
Nothing else this week.
-
Cantor Fitzgerald
American financial services company
-
Scotiabank
Canadian bank based in Toronto
-
Royal Bank of Canada
financial institution in Canada
Related events
- Royal Bank of Canada and Morgan Stanley lowered price targets for Amentum stock in August 2026.
- Financial firms including Raymond James Financial, Citigroup, and Royal Bank of Canada adjusted price targets for EOG Resources, Inc. on July 9, 2026.
- Scotiabank raised its price target and Bank of America upgraded its rating on May 27, 2026, with MarketBeat aggregating the data.
- Morgan Stanley lowered its price target on Dominion Energy stock, while Royal Bank of Canada raised its target price on the company.
- Jefferies Financial Group reaffirmed a 'buy' rating and issued a $45.00 target price for NewAmsterdam Pharma, Inc.
Coverage
Newest first; wire copies grouped- tickerreport.com
- themarketsdaily.com
- themarketsdaily.com
- dailypolitical.com
- themarketsdaily.com
- dailypolitical.com